Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 2617 - 2624 of 12016 results
Supreme Court Blocks OSHA Vaccine Rule for Large Employers
January 13, 2022| Blog| Viewpoint
(Updated) A Comprehensive Breakdown of OSHA’s COVID-19 Vaccination Rule
January 12, 2022| Blog| Viewpoint
Prominent Jewish Immigration Lawyer Pens New Book, Readies for Pittsburgh Appearance
January 12, 2022| News
Health Law Diagnosed — Mintz’s 2022 Health Law New Year’s Resolutions
January 12, 2022| Podcast| Viewpoint
CMS Proposes New Rules for Medicare Advantage and Part D
January 11, 2022| Blog| Viewpoint
Broker and Consultant Compensation Disclosures of General Agent Commissions Under the Consolidated Appropriations Act, 2021
January 11, 2022| Blog| Viewpoint
Opening the Door to the New Beginning
January 10, 2022| Article| Viewpoint
Court Issues Highly Anticipated Decision Regarding the Treatment of SPAC Sponsors and Directors
January 10, 2022| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
The Evolving Global Digital Infrastructure: Data Centers, AI, and the Next Wave of Connectivity
New York, NY
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|